Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
EV/Core EBITDA

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 9.319.987.267.948.95

What is the latest EV/Core EBITDA ratio of AUROBINDO PHARMA ?

The latest EV/Core EBITDA ratio of AUROBINDO PHARMA is 9.31 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar20259.31
Mar20249.98
Mar20237.26
Mar20227.94
Mar20218.95

How is EV/Core EBITDA of AUROBINDO PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 9.31
-6.71
Mar2024 9.98
37.47
Mar2023 7.26
-8.56
Mar2022 7.94
-11.28
Mar2021 8.95 -

Other Financial Ratios of AUROBINDO PHARMA


Compare EV/Core EBITDA ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹83,397.1 Cr 3.6% 15.1% 21.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹403,052.0 Cr 0.3% -3.7% -4.7% Stock Analytics
DIVIS LABORATORIES ₹169,336.0 Cr 2.4% 6.7% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,311.0 Cr -0.8% -1.5% 25.4% Stock Analytics
DR REDDYS LABORATORIES ₹111,264.0 Cr 7.9% 4.6% 4.6% Stock Analytics
CIPLA ₹105,484.0 Cr 5.5% 5.4% -18.5% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

3.6%

15.1%

21.2%

SENSEX

-0.4%

1.3%

0.8%


You may also like the below Video Courses